Cardinal Health, Inc. $CAH Stock Holdings Trimmed by Ranch Capital Advisors Inc.

Ranch Capital Advisors Inc. lowered its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 22.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,136 shares of the company’s stock after selling 5,697 shares during the period. Cardinal Health makes up 1.4% of Ranch Capital Advisors Inc.’s holdings, making the stock its 19th largest position. Ranch Capital Advisors Inc.’s holdings in Cardinal Health were worth $3,215,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Greykasell Wealth Strategies Inc. bought a new stake in shares of Cardinal Health in the 1st quarter worth $26,000. Jones Financial Companies Lllp raised its stake in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares in the last quarter. Atlantic Edge Private Wealth Management LLC raised its stake in shares of Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after buying an additional 75 shares in the last quarter. GW&K Investment Management LLC raised its stake in shares of Cardinal Health by 113.4% in the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after buying an additional 144 shares in the last quarter. Finally, Harbor Asset Planning Inc. bought a new stake in shares of Cardinal Health in the 2nd quarter worth $49,000. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 1.7%

Shares of CAH stock opened at $161.83 on Friday. Cardinal Health, Inc. has a 1-year low of $106.98 and a 1-year high of $168.44. The company has a market capitalization of $38.45 billion, a price-to-earnings ratio of 25.09, a P/E/G ratio of 1.35 and a beta of 0.71. The stock’s fifty day simple moving average is $152.75 and its 200-day simple moving average is $152.69.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter in the previous year, the company posted $1.84 earnings per share. Cardinal Health’s revenue for the quarter was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were paid a $0.5107 dividend. The ex-dividend date was Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. Cardinal Health’s payout ratio is 31.63%.

Insider Transactions at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 38,078 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the transaction, the insider owned 48,457 shares in the company, valued at $7,211,370.74. The trade was a 44.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Ola M. Snow sold 28,151 shares of the business’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the transaction, the insider owned 15,431 shares in the company, valued at $2,298,293.14. This trade represents a 64.59% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 271,676 shares of company stock valued at $40,489,525. Corporate insiders own 0.12% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Argus set a $189.00 target price on Cardinal Health in a report on Friday, August 22nd. Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 2nd. Jefferies Financial Group set a $150.00 target price on Cardinal Health in a report on Tuesday, August 12th. Wells Fargo & Company restated an “overweight” rating and issued a $185.00 target price (up from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Finally, Robert W. Baird lifted their target price on Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a report on Wednesday, August 13th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $166.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.